GL1X · GenesisL1 explorer

MolNFT v1 · #180472 · protein

Circulating SARS-cov-2 spike N439K variants maintain fitness while evading antibody-mediated immunity

7L0N · Monoclonal antibody S309 Fab light chain: “Circulating SARS-cov-2 spike N439K variants maintain fitness while evading antibody-mediated immunity”. X-ray diffraction, 8 ligands (NAG, MAN, BMA), 20 pockets (best druggability 0.74).…

PDB
7L0N
Type
protein
Length
3,304 residues
Chains
12
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Monoclonal antibody S309 Fab light chain; Monoclonal antibody S309 Fab heavy chain…
EC
3.4.17.23
UniProt
Q9BYF1, P0DTC2
Ligands
NAG, MAN, BMA, FUC, NA, ZN, CL, SO4
Pockets
20 · best druggability 0.74

Structure

x-ray diffraction · 10 distinct chains · 29% helix, 30% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
B, DMonoclonal antibody S309 Fab light chainprotein2136% helix, 52% strand—
AMonoclonal antibody S309 Fab heavy chainprotein2225% helix, 51% strand—
CMonoclonal antibody S309 Fab heavy chainprotein2247% helix, 52% strand—
L, NMonoclonal antibody S304 Fab light chainprotein2133% helix, 53% strand—
HMonoclonal antibody S304 Fab heavy chainprotein2127% helix, 56% strand—
MMonoclonal antibody S304 Fab heavy chainprotein2156% helix, 57% strand—
EAngiotensin-converting enzyme 2 (EC 3.4.17.23)protein57960% helix, 3% strandQ9BYF1
FAngiotensin-converting enzyme 2 (EC 3.4.17.23)protein59659% helix, 4% strandQ9BYF1
RSpike protein S1protein20314% helix, 29% strandP0DTC2
SSpike protein S1protein20114% helix, 30% strandP0DTC2

Ligands and binding sites

  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 13 copies · chains B, A, R, D, C, S, E, H, F, M
  • MAN · alpha-D-mannopyranose · sugar · 3 copies · chains B, R, D
  • BMA · beta-D-mannopyranose · sugar · 2 copies
  • FUC · alpha-L-fucopyranose · sugar · 2 copies · chains B, A, D, C
  • NA · Sodium ion · metal · 6 copies · chains L, H, R, F
  • ZN · Zinc ion · metal · 2 copies · chains E, F
  • CL · Chloride ion · ion · 27 copies · chains B, A, D, C, H, L, N, M, S, E, F, R
  • SO4 · Sulfate ion · ion · 2 copies · chains L, N
  • PGE · Triethylene glycol · additive · 2 copies · chains E, S
  • PG5 · 1-methoxy-2-[2-(2-methoxy-ethoxy]-ethane · additive · chains L, H
  • PG4 · Tetraethylene glycol · additive · chains N

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

20 pockets found on a 1 Å grid, 14 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
19920.740.77108PG5
25220.710.8047empty
35040.710.8048empty
47590.690.7674CL
57960.680.7572empty

Interfaces

17 interfaces between chains.

  • N–M · 1919 Ų buried · 10 hydrogen bonds · protein-protein
  • L–H · 1876 Ų buried · 13 hydrogen bonds · protein-protein
  • B–A · 1690 Ų buried · 13 hydrogen bonds · protein-protein
  • D–C · 1643 Ų buried · 11 hydrogen bonds · protein-protein
  • L–N · 1031 Ų buried · 15 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 29 disulfide, 11 glycan (disulfide, N-glycosylation).

Compared structures

  • 7L0N · Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading… · the same entry in another collection · chain R against R, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.